TOLLIP SNP and Antimicrobial Treatment Effect in Idiopathic Pulmonary Fibrosis

被引：0

作者：

Whalen, William ^{[1
]}

Berger, Kristin ^{[1
]}

Kim, John S. ^{[4
]}

Simmons, Will ^{[2
]}

Ma, Shwu-Fan ^{[4
]}

Kaner, Robert J. ^{[1
,3
]}

Martinez, Fernando J. ^{[1
]}

Anstrom, Kevin J. ^{[5
]}

Parfrey, Helen ^{[6
,7
]}

Maher, Toby M. ^{[8
,9
,10
]}

Hammond, Matthew ^{[11
,12
]}

Clark, Allan B. ^{[11
,12
]}

Thickett, David ^{[13
]}

Jenkins, R. Gisli ^{[9
,10
]}

Wilson, Andrew M. ^{[12
]}

Noth, Imre ^{[4
]}

机构：

[1] New York Presbyterian Weill Cornell Med, Div Pulm & Crit Care, Dept Med, New York, NY 10032 USA

[2] New York Presbyterian Weill Cornell Med, Dept Populat Hlth Sci, Div Biostat, New York, NY USA

[3] New York Presbyterian Weill Cornell Med, Dept Genet Med, New York, NY USA

[4] Univ Virginia, Dept Med, Sch Med, Charlottesville, VA USA

[5] Univ North Carolina Chapel Hill, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA

[6] Univ Cambridge, Cambridge, England

[7] Royal Papworth Hosp Natl Hlth Serv Fdn Trust, Cambridge, England

[8] Univ Southern Calif, Los Angeles, CA USA

[9] Imperial Coll London, Natl Heart & Lung Inst, Imperial Biomed Res Ctr, London, England

[10] Imperial Coll London, Natl Inst Hlth & Care Res, Margaret Turner Warwick Ctr Fibrosing Lung Dis, London, England

[11] Univ East Anglia, Norwich Clin Trials Unit, Norwich, England

[12] Univ East Anglia, Norwich Med Sch, Norwich, England

[13] Univ Birmingham, Inst Inflammat & Aging, Birmingham, England

来源：

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2024年 / 210卷 / 04期

关键词：

DOXYCYCLINE; SUSCEPTIBILITY; THERAPY; DEATH;

D O I：

10.1164/rccm.202312-2224LE

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：508 / 511

页数：4

共 50 条

[1] Micrornas Regulate The Expression Of Tollip Gene Involved In Idiopathic Pulmonary Fibrosis Susceptibility
Ma, S. -F.
Huang, R. -T.
Huang, Y.
Vij, R.
Oldham, J.
Flores, C.
Fang, Y.
Noth, I.
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
[2] Treatment of idiopathic pulmonary fibrosis
Valeyre, Dominique
Dion, Genevieve
[J]. BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2010, 194 (02): : 367 - 381
[3] TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS
NICOD, LP
[J]. SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1995, 125 (10) : 483 - 488
[4] Treatment of idiopathic pulmonary fibrosis
Daniels, Craig E.
Ryu, Jay H.
[J]. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2006, 27 (06) : 668 - 676
[5] Treatment of Idiopathic Pulmonary Fibrosis
Abuserewa, Sherif T.
Duff, Richard
Becker, Gregory
[J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (05)
[6] THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS
WINTERBAUER, RH
[J]. CHEST, 1991, 100 (01) : 233 - 235
[7] Treatment of Idiopathic Pulmonary Fibrosis
Carlos, William G.
Strek, Mary E.
Wang, Tisha S.
Patel, Harin
Raghu, Ganesh
Wilson, Kevin C.
Thomson, Carey C.
[J]. ANNALS OF THE AMERICAN THORACIC SOCIETY, 2016, 13 (01) : 115 - 117
[8] No effect of danazol treatment in patients with advanced idiopathic pulmonary fibrosis
Hoffman, Thijs W.
van Moorsel, Coline H. M.
van der Vis, Joanne J.
Biesma, Douwe H.
Grutters, Jan C.
[J]. ERJ OPEN RESEARCH, 2023, 9 (05)
[9] Mechanisms of Colchicine Effect in the Treatment of Asbestosis and Idiopathic Pulmonary Fibrosis
D.J. Addrizzo-Harris
T.J. Harkin
K.M. Tchou-Wong
G. McGuinness
R. Goldring
D. Cheng
D.W.N. Rom
[J]. Lung, 2002, 180 : 61 - 72
[10] Effect of sildenafil added to antifibrotic treatment in idiopathic pulmonary fibrosis
Jieun Kang
Jin Woo Song
[J]. Scientific Reports, 11

← 1 2 3 4 5 →